43 results on '"Tiwari, Arun"'
Search Results
2. T60. PHARMACOGENOMIC TESTING FOR ADULTS WITH INTELLECTUAL DISABILITY AND AUTISM SPECTRUM DISORDER: A PRELIMINARY REPORT
3. W5. INVESTIGATING THE GENETIC LINK BETWEEN HEART RATE VARIABILITY (HRV) AND ANXIETY DISORDERS: POLYGENIC RISK SCORE OVERLAP AND ASSOCIATION OF HRV GENOME-WIDE POLYMORPHISMS WITH ANXIETY
4. T82. ASSOCIATION OF SCHIZOPHRENIA POLYGENIC RISK SCORES WITH TREATMENT-RESISTANT SCHIZOPHRENIA
5. CROSS-DISORDER INVESTIGATION OF STRESS SYSTEM RELATED GENE (CRHR1, CRHR2, FKBP5, NR3C1, NR3C2, SKA2, SLC6A4, HTR2A) ASSOCIATIONS WITH IMPROVEMENT IN A DIMENSIONAL MEASURE OF DEPRESSION
6. ASSESSMENT OF POLYGENIC RISK SCORES OF BOTH ANXIETY AND HEART RATE VARIABILITY IN ANXIETY-RELATED PHENOTYPES
7. TU28. BIGENOMIC ASSOCIATION STUDY OF ACCELEROMETER-DERIVED AND SELF-REPORTED SLEEP PROPERTIES ACROSS UK BIOBANK PARTICIPANTS WITH LIFETIME MAJOR DEPRESSIVE DISORDER
8. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia
9. S12EXAMINATION OF STARTLE-ASSOCIATED GENES AND THE CHANGE IN ANXIETY SYMPTOM SEVERITY FOLLOWING PHARMACOLOGICAL TREATMENT
10. 59 POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
11. M76 PHARMACOGENETICS OF ANTIDEPRESSANT RESPONSE IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDERS
12. ASSOCIATION OF CYP2D6 METABOLIZER STATUS WITH ANTIDEPRESSANT INDUCED MANIA
13. SU15USING GENETIC MODULATORS OF THE STARTLE RESPONSE TO INVESTIGATE ANXIETY ETIOLOGY
14. F24SYSTEMS BIOLOGY APPROACH TO EVALUATE GENETIC FACTORS OF ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS WITH SCHIZOPHRENIA
15. PHARMACOGENETIC TESTING HELPS TO REDUCE BENZODIAZEPINE AND SLEEP MEDICATION USE IN PATIENTS WITH ANXIETY
16. SU97EFFECT OF PHARMACOGENETICS-GUIDED ANTIDEPRESSANT TREATMENT ON SUICIDAL IDEATION
17. VALIDATION STUDY IN TWO GENOME-WIDE SIGNIFICANT RISK VARIANTS FOR ANTIPSYCHOTIC INDUCED WEIGHT GAIN
18. F45INVESTIGATING THE GENETICS OF SLEEP DISTURBANCES IN DEPRESSION
19. UNRAVELING GENOMIC CONTRIBUTIONS TO VENLAFAXINE REMISSION IN OLDER ADULTS WITH LATE-LIFE DEPRESSION USING A GENOME-WIDE APPROACH
20. GENOME-WIDE ANALYSES OF REMISSION ON VENLAFAXINE TREATMENT IN OLDER ADULTS WITH LATE-LIFE DEPRESSION
21. COMBINATORIAL PHARMACOGENOMIC TESTING IMPROVES GENERALIZED ANXIETY DISORDER TREATMENT RESPONSE AND DECREASES BENZODIAZAPINE USE
22. THE GLUTAMATE RECEPTOR - GRM3 GENE AND ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA
23. F103NEW GENETIC FINDINGS IN TARDIVE DYSKINESIA: FROM CYP2D6 TO C4
24. GENOME-WIDE ASSOCIATION STUDIES OF SUICIDAL IDEATION DURING PSYCHOTROPIC MEDICATION
25. F110DNA METHYLATION OF STRESS SYSTEM GENES (CRHR1, CRHR2, FKBP5, NR3C1, NR3C2, SKA2) MAY BE ASSOCIATED WITH ANTIDEPRESSANT TREATMENT OUTCOME IN CLINICAL DEPRESSION
26. SU101EVALUATION OF GLUTAMATE RECEPTOR GENE (GRID2, GRIK2) VARIANTS IN OBSESSIVE-COMPULSIVE DISORDER RISK, SYMPTOM SEVERITY, AND ANTIDEPRESSANT TREATMENT RESPONSE
27. F42POST-GWAS IN SILICO BIOLOGICAL CHARACTERIZATION OF VARIANTS ASSOCIATED WITH VENLAFAXINE TREATMENT REMISSION IN LATE-LIFE DEPRESSION
28. DNA METHYLATION AND 5-HTTLPR GENOTYPE OF THE SEROTONIN TRANSPORTER GENE (SLC6A4) IN ANTIDEPRESSANT TREATMENT RESPONSE OF MAJOR DEPRESSIVE DISORDER
29. TU9. EXPLORATORY TARGETED GENE ANALYSIS OF RESTING HEART RATE VARIABILITY TO IDENTIFY ANXIETY-RELATED MARKERS
30. Preliminary Model For The Genetic Prediction Of Clozapine Response
31. Polygenic Risk Score Analysis Of Suicidal Behaviour Severity
32. GENETIC VARIATION AND EPIGENETIC MODIFICATION OF SKA2: ASSOCIATIONS WITH OBSESSIVE-COMPULSIVE DISORDER DISEASE RISK AND SYMPTOM SEVERITY
33. M85 - DNA METHYLATION AND 5-HTTLPR GENOTYPE OF THE SEROTONIN TRANSPORTER GENE (SLC6A4) IN ANTIDEPRESSANT TREATMENT RESPONSE OF MAJOR DEPRESSIVE DISORDER
34. SU86 - VALIDATION STUDY IN TWO GENOME-WIDE SIGNIFICANT RISK VARIANTS FOR ANTIPSYCHOTIC INDUCED WEIGHT GAIN
35. SU83 - COMBINATORIAL PHARMACOGENOMIC TESTING IMPROVES GENERALIZED ANXIETY DISORDER TREATMENT RESPONSE AND DECREASES BENZODIAZAPINE USE
36. SU84 - THE GLUTAMATE RECEPTOR - GRM3 GENE AND ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA
37. SU10 - PHARMACOGENETIC TESTING HELPS TO REDUCE BENZODIAZEPINE AND SLEEP MEDICATION USE IN PATIENTS WITH ANXIETY
38. SA81 - UNRAVELING GENOMIC CONTRIBUTIONS TO VENLAFAXINE REMISSION IN OLDER ADULTS WITH LATE-LIFE DEPRESSION USING A GENOME-WIDE APPROACH
39. SA80 - ASSOCIATION OF CYP2D6 METABOLIZER STATUS WITH ANTIDEPRESSANT INDUCED MANIA
40. SA7 - GENOME-WIDE ASSOCIATION STUDIES OF SUICIDAL IDEATION DURING PSYCHOTROPIC MEDICATION
41. T38 - Preliminary Model For The Genetic Prediction Of Clozapine Response
42. T19 - Polygenic Risk Score Analysis Of Suicidal Behaviour Severity
43. M33 - GENETIC VARIATION AND EPIGENETIC MODIFICATION OF SKA2: ASSOCIATIONS WITH OBSESSIVE-COMPULSIVE DISORDER DISEASE RISK AND SYMPTOM SEVERITY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.